Healthtech Startups

Flora Surfaces (Flora Coatings) develops single-component, ready-to-use biobased sustainable coatings and surface treatments, including anticorrosion, antimicrobial, oleophobic, and high-temperature-resistant products. Its coatings serve the aerospace, automotive, marine, healthcare, construction, oil and gas, and agriculture/packaging industries.

1 investor

Floracene provides independent surgery centers with software to identify lower-cost clinically equivalent orthopedic and spine implants based on their existing manufacturer contracts. The platform helps physician-owners reduce implant costs by presenting alternative options that meet clinical requirements for specific procedures.

1 investor

FloraWorks develops rare and novel cannabinoid-based therapeutic ingredients, focusing on non-intoxicating cannabinoids validated through peer-reviewed research and toxicology testing. It targets the health, wellness, and supplement markets, aiming to bring scientifically validated cannabinoid products to mainstream retailers.

1 investor

Flore offers a microbiome "test-to-treat" program in which accredited labs run at-home gut microbiome and neurotransmitter urine tests, and Flore then builds and manufactures a personalized supplement formula based on the individual's results. The formulas target the gut–brain axis and other body systems such as digestion, metabolism, immunity, and mood, and are updated when a customer retests.

1 investor

Florence provides an online NCLEX exam preparation platform for US and foreign-trained nurses, offering interactive lectures, practice questions, and personalized study plans. Its offering includes an AI-based tutor, 3D anatomy models, mock exams, and concept-based review courses in the nursing education space.

1 investor

Flouria is a digital women's health clinic that connects patients with specialised doctors for testing, insights, and personalised treatment plans across areas like perimenopause, postmenopause, postpartum, PMOS/PCOS, and fertility. Care is delivered through its app, where users chat and video call with experts, access courses, and track symptoms, with a stated focus on Europe and the Netherlands.

1 investor

Flourish Research operates a network of clinical trial research sites specializing in patient recruitment and retention across therapeutic areas including cardiometabolic disease, neuroscience, oncology, and infectious diseases. The company serves pharmaceutical sponsors and contract research organizations (CROs) by providing integrated site infrastructure, patient access, and standardized operations for studies across all research phases.

1 investor

Flow Nutrition manufactures dietary supplements, including Longevity 4.0, a formulated blend of natural substances designed to support cellular processes and slow aging. The company produces all products in-house in Jablonec nad Nisou, Czech Republic.

1 investor

Flow provides a consumer-facing neurostimulation device using transcranial direct current stimulation (tDCS) for depression treatment. The technology is clinically validated and available for at-home use to balance activity in mood-regulating brain regions.

1 investor

flowbone develops a first-in-class injectable bioactive hydrogel that triggers the body to deposit its own minerals and form new bone, aimed at preventing osteoporotic hip fractures. It is a preclinical-stage medical technology company spun off from EPFL's Laboratory of Biomechanical Orthopedics, with products still in development.

1 investor

FlowRx builds deterministic AI automation for pharmacy workflows such as data entry, eRx processing, refills, billing, prior authorization, and inventory optimization. It targets independent pharmacies, overlaying existing systems with compliance dashboards and human review of exceptions.

1 investor

flowww provides cloud-based management software for beauty, aesthetic medicine, health, and wellness clinics, with tools for clinical records, appointment booking, digital consent signatures, marketing automation, and reporting. It also offers a medical AI assistant that fills out forms automatically and automates repetitive clinical and operational tasks.

1 investor

Fluidx Medical Technology develops embolic devices for use in embolization procedures that are designed to be easy to use, controllable, visible, and durable. The company serves interventional physicians and patients requiring embolization treatments.

1 investor

Flume has developed a patented redesign of the urinary (Foley) catheter that moves the drainage holes and eliminates the exposed tip to reduce infection, blockage, and patient pain. The product has FDA 510(k) clearance for urethral and suprapubic use and is aimed at clinicians and catheter patients.

1 investor

Fluorobiotech develops molecular enzymes—using its patented SelfPrep technology—for in vitro transcription, mRNA synthesis, and transcriptomics, serving researchers, developers, and manufacturers with molecular biology reagents. The company produces ISO 13485-certified enzymes at scales from micrograms to grams for both preclinical studies and commercial volumes.

1 investor

FlutteSpace is an AI-powered medical technology company that reimagines radiology workflows by combining machine learning with radiologist expertise. The startup serves radiologists and healthcare providers globally to improve diagnostic quality and healthcare accessibility.

1 investor

FluxWear develops SHIFT, a wearable device using pulsed electromagnetic field (PEMF) therapy to help reduce pain, stress, and anxiety, with a focus on neuropathic pain among young people. The product targets consumers as well as parents, counselors, nurses, physical therapists, corporate wellness programs, and medical institutions in the US.

1 investor

Flymedi operates an online directory and matching service that connects patients with verified clinics and doctors abroad for medical treatments such as bariatric and general surgery. It provides price quotes, doctor-reviewed medical guides, and patient reviews, ranking providers via its FlymediScore and earning success fees from clinics rather than from patients.

1 investor

Pelvital is a medical device company that develops FDA-cleared in-home treatments for stress urinary incontinence and pelvic floor muscle weakness in women, using a proprietary mechanotherapy technology. The company serves women suffering from incontinence and healthcare providers seeking non-surgical treatment alternatives.

1 investor

Flyway Health runs AI agents on healthcare claims data to answer commercial pharma market questions, encoding common data pitfalls so findings survive validation before delivery. Findings are reviewed by analysts with commercial pharma experience and delivered within five business days, naming the specific HCPs and sites behind each conclusion.

1 investor

A healthcare industry advisory and consulting firm that partners with organizations across their growth lifecycle and digital transformation initiatives.

1 investor

Focal MD, founded in 2022, supports and advances medical innovation through global strategic investments. The company operates in the medical technology and innovation space.

1 investor

Focal Healthcare is a medical device company that builds image-guided systems for physicians to perform targeted prostate procedures such as fusion biopsy and focal therapy. Its products aim to improve the accuracy and accessibility of prostate cancer diagnosis and treatment.

1 investor

Focus At Will Labs is a US company operating a music streaming service designed to support concentration. Its catalog uses phase-sequenced instrumental tracks intended to extend attention span during tasks such as studying, reading, and writing.

1 investor